Piper Sandler Bolsters Fixed Income Team with the Addition of Brian Vescio
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian Vescio as a ...
ANI earns bullish view at Piper Sandler on portfolio mix
ANI Pharmaceuticals (ANIP) stock gains as Piper Sandler gives it an overweight rating with $68 price target, citing its ...
The Bond Buyer2d
Labor grumbles as Minneapolis hospital chain navigates downgrades
After Minnesota's second-largest healthcare employer was downgraded by rating agencies, the Minnesota Nurses Association took ...
Northern Oil And Gas (NOG) Gets a Hold from Piper Sandler
Piper Sandler analyst Mark Lear maintained a Hold rating on Northern Oil And Gas (NOG – Research Report) today and set a price target of ...
Piper Sandler Sticks to Its Hold Rating for Sleep Number (SNBR)
Piper Sandler analyst Peter Keith maintained a Hold rating on Sleep Number (SNBR – Research Report) today and set a price target of ...
manilatimes16h
Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics ...
Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock
SAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CAPR), a biotechnology company developing transformative cell and ...
Morningstar16d
Upstream Bio Announces Pricing of Upsized Initial Public Offering
Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, by telephone at (800) 747-3924 or by email at [email protected]; or William Blair ...
Morningstar8d
CAMP4 Announces Pricing of Initial Public Offering
6105, or by emailing [email protected]; Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by telephone at (800) 747-3924 ...
CAMP4 Therapeutics: CAMP4 Announces Pricing of Initial Public Offering
CAMP4 Therapeutics Corporation ("CAMP4") (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics ...